Sailaja Puttagunta
Chief Tech/Sci/R&D Officer chez ITERUM THERAPEUTICS PLC
Fortune : 15 968 $ au 31/03/2024
Postes actifs de Sailaja Puttagunta
Sociétés | Poste | Début | Fin |
---|---|---|---|
ITERUM THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 13/12/2021 | - |
Historique de carrière de Sailaja Puttagunta
Anciens postes connus de Sailaja Puttagunta
Sociétés | Poste | Début | Fin |
---|---|---|---|
BIOMX INC. | Chief Tech/Sci/R&D Officer | 28/10/2019 | 13/12/2021 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Chief Tech/Sci/R&D Officer | 01/12/2018 | 01/10/2019 |
ITERUM THERAPEUTICS PLC | Corporate Officer/Principal | 01/01/2016 | 01/12/2018 |
ALLERGAN PLC | Chief Tech/Sci/R&D Officer | 01/01/2015 | 01/01/2016 |
DURATA THERAPEUTICS INC | Chief Tech/Sci/R&D Officer | 01/06/2012 | 01/12/2014 |
Formation de Sailaja Puttagunta
Gandhi Medical College & Hospital | Undergraduate Degree |
New York University School of Medicine | Graduate Degree |
Statistiques
Internationale
Irlande | 3 |
Israël | 3 |
Etats-Unis | 3 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 5 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sectorielle
Health Technology | 6 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
ITERUM THERAPEUTICS PLC | Health Technology |
BIOMX INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Health Technology |
Durata Therapeutics, Inc.
Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Durata Therapeutics, Inc. develops and commercializes novel therapeutics for infectious diseases and acute illnesses. The company was founded on November 4, 2009 and is headquartered in Chicago, IL. | Health Technology |
- Bourse
- Insiders
- Sailaja Puttagunta
- Expérience